30th Sep 2013 14:41
LONDON (Alliance News) - Dechra Pharmaceuticals PLC Monday said that Chief Financial Officer Anne-Francoise Nesmes, was granted nil cost option share awards on Friday.
Type of award | Number of shares subject to award | Vesting date |
Nil cost option | 41,739 | 30 June 2014 |
Nil cost option | 41,739 | 30 June 2015 |
Dechra Pharmaceuticals shares were trading at 705.00 pence per share Monday afternoon, down 0.8%.
By Rowena Harris-Doughty; [email protected]; @rharrisdoughty
Copyright © 2013 Alliance News Limited. All Rights Reserved.
Related Shares:
DPH.L